Cite
Diagnostic use of computational retrotransposon detection: Successful definition of pathogenetic mechanism in a ciliopathy phenotype
MLA
Tomu Kuchikata, et al. “Diagnostic Use of Computational Retrotransposon Detection: Successful Definition of Pathogenetic Mechanism in a Ciliopathy Phenotype.” American Journal of Medical Genetics. Part A, vol. 173, no. 5, Sept. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b745a9db60238547d7112f5de04f3abc&authtype=sso&custid=ns315887.
APA
Tomu Kuchikata, Toshiki Takenouchi, Sahoko Miyama, Mineko Fujiwara, Kenjiro Kosaki, Shiro Yamada, Tomoko Uehara, & Hiroshi Yoshihashi. (2016). Diagnostic use of computational retrotransposon detection: Successful definition of pathogenetic mechanism in a ciliopathy phenotype. American Journal of Medical Genetics. Part A, 173(5).
Chicago
Tomu Kuchikata, Toshiki Takenouchi, Sahoko Miyama, Mineko Fujiwara, Kenjiro Kosaki, Shiro Yamada, Tomoko Uehara, and Hiroshi Yoshihashi. 2016. “Diagnostic Use of Computational Retrotransposon Detection: Successful Definition of Pathogenetic Mechanism in a Ciliopathy Phenotype.” American Journal of Medical Genetics. Part A 173 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b745a9db60238547d7112f5de04f3abc&authtype=sso&custid=ns315887.